Asterias Biotherapeutics Launches New Website: Asteriasbiotherapeutics.com
5/21/2014 9:13:46 AM
MENLO PARK, Calif. & ALAMEDA, Calif.--(BUSINESS WIRE)--Asterias Biotherapeutics, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX) that is developing clinical-stage stem cell therapeutic assets acquired from Geron Corporation, today announced the launch of its new website, www.asteriasbiotherapeutics.com. The website provides information about Asterias, including its core technologies, areas of product development focus, intellectual property portfolio, key publications, SEC filings, and management team.
Help employers find you! Check out all the jobs and post your resume.
comments powered by